Cannabinoid Clinic: CBN
Updated: Mar 24
This article is brought to you by the new Higher Learning LV Core Cannabis course.
Welcome to homework assignment 1.14 of the Core Cannabis Training Track from Higher Learning LV. When you complete this assignment, simply click the link at the bottom of the article to return to the master page for this training track.
Welcome to Cannabinoid Clinic, an education project powered by Higher Learning LV. This series provides cannabis and hemp industry professionals with easily digested cannabinoid profiles that ask little of your time—but provide plenty of science-based information.
There are two categories of cannabinoids: Phytocannabinoids and endocannabinoids. Phytocannabinoids are those produced by cannabis/marijuana/hemp, while endocannabinoids are made by the human body. This series covers both.
CBN molecular structure
What is CBN?
Cannabinol (CBN) is the result of CBNA, the acidic precursor for this important cannabinoid. It is considered a minor cannabinoid because it is typically available in relatively low volumes compared to major cannabinoids such as cannabidiol (CBD) and tetrahydrocannabiol (THC) (under one percent).
Mildly psychoactive, CBN may help patients suffering from a range of conditions, including anxiety, sleep disorders, and pain.
Only mildly psychoactive (about 25 percent of the potency of delta-9 THC), CBN may help patients suffering from a range of conditions, including anxiety, sleep disorders, and pain. CBN has the distinction of having been the first cannabinoid to be identified and chemically isolated from the cannabis plant in 1896 by a group of British chemists.
To see the Fast Facts and Research Studies sections that have been removed from this no-cost training asset, enroll in Core Cannabis.
Return to the Core Cannabis Training Track master page.
Like what you just read? Check out our new Cannabis for Cancer Hub that features links to all of our articles about marijuana for cancer.